Pancreatic vasopressin V1b receptors: Characterization in In-R1-G9 cells and localization in human pancreas

American Journal of Physiology - Endocrinology and Metabolism

Volumn 285, Issue 3 48-3, 2003, Pages

  Folny, Viviane ^a   Raufaste, Danielle ^a   Lukovic, Ludovit ^a   Pouzet, Brigitte ^a   Rochard, Pierrick ^a   Pascal, Marc ^a   Serradeil Le Gal, Claudine ^a  

^a SANOFI   (France)

Author keywords

Arginine vasopressin V1b receptors; Glucagon; SSR 149415

Indexed keywords

1 [5 CHLORO 1 (2,4 DIMETHOXYLPHENYLSULFONYL) 2,3 DIHYDRO 3 (2 METHOXYPHENYL) 2 OXO 1H INDOL 3 YL] 4 HYDROXY N,N DIMETHYL 2 PYRROLIDINECARBOXAMIDE; ARGIPRESSIN; GLUCAGON; INSULIN; OXYTOCIN; SOMATOSTATIN; UNCLASSIFIED DRUG; VASOPRESSIN RECEPTOR ANTAGONIST; VASOPRESSIN V1 RECEPTOR; VASOPRESSIN V1B RECEPTOR; VASOPRESSIN V2 RECEPTOR; 1 (5 CHLORO 1 ((2,4 DIMETHOXYPHENYL)SULFONYL) 3 (2 METHOXYPHENYL) 2 OXO 2,3 DIHYDRO 1H INDOL 3 YL) 4 HYDROXY N,N DIMETHYL 2 PYRROLIDINECARBOXAMIDE; 1-(5-CHLORO-1-((2,4-DIMETHOXYPHENYL)SULFONYL)-3-(2-METHOXYPHENYL)-2-OXO-2,3-DIHYDRO-1H-INDOL-3-YL)-4-HYDROXY-N,N-DIMETHYL-2-PYRROLIDINECARBOXAMIDE; CALCIUM; DIAGNOSTIC AGENT; HORMONE ANTAGONIST; INDOLE DERIVATIVE; MESSENGER RNA; PYRROLIDINE DERIVATIVE; RELCOVAPTAN; TRITIUM; VASOCONSTRICTOR AGENT; VASOPRESSIN DERIVATIVE; VASOPRESSIN RECEPTOR;

ARTICLE; BINDING AFFINITY; CALCIUM CELL LEVEL; CELL PROLIFERATION; COMPETITIVE INHIBITION; CONTROLLED STUDY; GLUCAGON RELEASE; HAMSTER; HORMONAL REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LANGERHANS CELL; PANCREAS; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOMATOSTATIN CELL; STEREOCHEMISTRY; ANIMAL; BINDING COMPETITION; CELL CULTURE; CELL DIVISION; CYTOLOGY; DRUG EFFECT; GENETICS; GLUCAGONOMA; METABOLISM; PANCREAS ISLET;

ANIMALS; BINDING, COMPETITIVE; CALCIUM; CELL DIVISION; CRICETINAE; GLUCAGON; GLUCAGONOMA; HORMONE ANTAGONISTS; HUMANS; IMMUNOHISTOCHEMISTRY; INDOLES; ISLETS OF LANGERHANS; PYRROLIDINES; RECEPTORS, VASOPRESSIN; RNA, MESSENGER; TRITIUM; TUMOR CELLS, CULTURED; VASOCONSTRICTOR AGENTS; VASOPRESSINS;

EID: 0041965818     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00148.2003     Document Type: Article

References (33)

1. Aguilera G and Rabadan-Diehl C. Vasopressinergic regulation of the hypothalamic-pituitary-adrenal axis: implications for stress adaptation. Regul Pept 96: 23-29, 2000.
2. Amico JA, Finn FM, and Haldar J. Oxytocin and vasopressin are present in human and rat pancreas. Am J Med Sci 296: 303-307, 1988.
3. Bankir L, Bardoux P, and Ahloulay M. Vasopressin and diabetes mellitus. Nephron 87: 8-18, 2001.
4. Burbach JPH, Adan RA, Lolait SJ, van Leeuwen FW, Mezey E, Palkovits M, and Barberis C. Molecular neurobiology and pharmacology of the vasopressin/oxytocin receptor family. Cell Mol Neurobiol 15: 573-595, 1995.
5. Cheng Y and Prusoff WH. Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22: 3099-3108, 1973.
6. Connel R. Glucagon antagonists for the treatment of type 2 diabetes. Exp Opin Ther Patents 9: 701-709, 1999.
7. 3 pituitary vasopressin receptor. FEBS Lett 356: 215-220, 1994.
8. 3) and corticotrophin-releasing hormone receptor genes in corticotroph tumours. Clin Endocrinol (Oxf) 49: 475-482, 1998.
9. Dreifuss JJ, Tribollet E, Goumaz M, Dubois-Dauphin M, and Raggenbass M. Vasopressin receptor localization and neuronal responsiveness in the rat brain. In: Vasopressin, edited by Jard S and Jamison R. Paris: John Libbey Eurotext, 1991, p. 159-166.
10. Dunning BE, Moltz JH, and Fawcett CP. Modulation of insulin and glucagon secretion from the perfused rat pancreas by the neurohypophysial hormones and by desamino-D-arginine vasopressin (DDAVP). Peptides 5: 871-875, 1984.
11. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260: 3440-3450, 1985.
12. Hurbin A, Orcel H, Alonso G, Moos F, and Rabie A. The vasopressin receptors colocalize with vasopressin in the magno-cellular neurons of the rat supraoptic nucleus and are modulated by water balance. Endocrinology 143: 456-466, 2002.
13. 1b receptors. Am J Physiol Endocrinol Metab 269: E1095-E1100, 1995.
14. 1b vasopressin receptor gene. Proc Natl Acad Sci USA 92: 6783-6787, 1995.
15. Munson PJ and Rodbard D. Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 107: 220-239, 1980.
16. North WG, Fay MJ, Longo KA, and Du J. Expression of all known vasopressin receptor subtypes by small cell tumors implies a multifaceted role for this neuropeptide. Cancer Res 58: 1866-1871, 1998.
17. 1 receptor of rat, rhesus and human tissues. Life Sci 50: 1953-1958, 1992.
18. Richardson SB, Eyler N, Twente S, Monaco M, Altszuler N, and Gibson M. Effects of vasopressin on insulin secretion and inositol phosphate production in a hamster beta cell line (HIT). Endocrinology 126: 1047-1052, 1990.
19. Rorsman P, Ashcroft FM, and Berggren PO. Regulation of glucagon release from pancreatic A-cells. Biochem Pharmacol 41: 1783-1790, 1991.
20. 1b vasopressin receptor: evidence for its expression in extra-pituitary tissues. Biochem Biophys Res Commun 212: 751-757, 1995.
21. 1b vasopressin receptor. Biochem Pharmacol 53: 1711-1717, 1997.
22. 1a antagonist, on human vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 268: H404-H410, 1995.
23. 2 receptor antagonist. J Clin Invest 98: 2729-2738, 1996.
24. 1a receptors. J Clin Invest 92: 224-231, 1993.
25. 1b receptor antagonist. J Pharmacol Exp Ther 300: 1122-1130, 2002.
26. Stock S, Fastbom J, Bjorkstrand E, Ungerstedt U, and Uvnas-Moberg K. Effects of oxytocin on in vivo release of insulin and glucagon studied by microdialysis in the rat pancreas and autoradiographic evidence for [3H] oxytocin binding sites within the islets of Langerhans. Regul Pept 30: 1-13, 1990.
27. 1b vasopressin receptor. J Biol Chem 269: 27088-27092, 1994.
28. Takaki R, Ono J, Nakamura M, Yokogawa Y, Kumae S, Hiraoka T, Yamaguchi K, Hamaguchi K, and Uchida S. Isolation of glucagon-secretion cell lines by cloning insulinoma cells. In Vitro Cell Dev Biol 22: 120-126, 1986.
29. Thibonnier M, Conarty DM, Preston JA, Wilkins PL, Berti-Mattera LN, and Mattera R. Molecular pharmacology of human vasopressin receptors. In: Vasopressin and Oxytocin, edited by Zingg HH, Bourque CW, and Bichet DG. New York: Plenum, 1998, p. 251-276.
30. 1b pituitary vasopressin receptor. J Mol Endocrinol 22: 251-260, 1999.
31. (2+)-dependent and -independent pathways. Br J Pharmacol 129: 257-264, 2000.
32. Yibchok-anun S, Cheng H, Heine PA, and Hsu WH. Characterization of receptors mediating AVP- and OT-induced glucagon release from the rat pancreas. Am J Physiol Endocrinol Metab 277: E56-E62, 1999.
33. 1b receptors. Life Sci 63: 1871-1878, 1998.